[Form 4] Life360, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 3 filing dated 07/01/2025 records the initial beneficial ownership of securities by Cassandra L. Hernandez-Monteon, recently named Interim CFO & Secretary of Genasys Inc. (GNSS). She directly owns 6,540 common shares and 1,166 unvested RSUs, plus an indirect interest in 1,913 shares held by her spouse. The executive also holds two option grants totaling 40,000 shares: 20,000 options exercisable at $1.70 (expire 12/12/2030) and 20,000 options at $2.59 (expire 12/12/2031). Each grant vests in equal one-third installments beginning 12/12/2024 and 12/12/2025, respectively. No open-market purchases or sales are reported; the filing is purely a disclosure required upon becoming a Section 16 officer.

Insights

Financial Analyst

TL;DR: Routine Form 3 shows modest insider stake and standard option grants; neutral for GNSS trading outlook.

The filing confirms that the new Interim CFO holds roughly 9,619 GNSS shares (direct, RSU, and indirect combined) and has incentives aligned through 40,000 service-based options priced close to recent historical lows ($1.70–$2.59). No purchases, sales, or performance-based awards are involved, implying neither bullish nor bearish insider sentiment. Given GNSS’s ~39 million shares outstanding, the disclosed stake is immaterial (<0.03%) and should not affect valuation or liquidity.

Corporate Governance Specialist

TL;DR: Filing formalizes Hernandez-Monteon as Section 16 officer; transparency positive for governance, but financial impact negligible.

By filing Form 3, Genasys meets SEC Section 16 compliance, signalling orderly governance amid leadership transition. Equity awards follow standard three-year vesting, encouraging retention without excessive dilution. However, the absence of market transactions or performance triggers limits the filing’s materiality for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burke Russell John

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	07/10/2025		S(1)		2,249	D	$63.9(2)	200,377(3)	D
Common stock	07/10/2025		S(1)		855	D	$64.2(4)	199,522(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024. The Rule 10b5-1 trading plan is a written, preestablished trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.14 to $64.13, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

3. Includes 111,231 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.14 to $64.37, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Remarks:

	/s/ Allison Chang, Attorney-in-Fact	07/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many GNSS shares does Interim CFO Cassandra Hernandez-Monteon own directly?

She directly owns 6,540 common shares and 1,166 unvested RSUs.

What stock options were disclosed in the July 2025 Form 3 for GNSS?

Two grants of 20,000 options each: one exercisable at $1.70 (exp. 12/12/2030) and one at $2.59 (exp. 12/12/2031).

When do the disclosed GNSS options vest?

Both grants vest in one-third annual installments; first grant starts 12/12/2024, second starts 12/12/2025.

Are there any open-market purchases or sales in this Form 3?

No. The filing only reports existing holdings and option grants—no transactions occurred.

How many GNSS shares are held indirectly by the officer?

She reports 1,913 shares held indirectly through her spouse.